AKT1 and Sepsis: Current evidence demonstrates that sepsis-induced activation of the AKT signaling pathway leads to upregulation of downstream effectors including MMP-9 and COX-2, accompanied by elevated inflammatory cytokine levels, ultimately contributing to intestinal barrier dysfunction and multi-organ injury [49, 50].